Musa Tariq - 15 Feb 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Musa Tariq
Issuer symbol
GH
Transactions as of
15 Feb 2026
Net transactions value
$0
Form type
4
Filing time
17 Feb 2026, 18:31:43 UTC
Previous filing
16 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tariq Musa Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Musa Tariq 17 Feb 2026 0001968281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +250 +3% $0.000000 8,493 15 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -250 -7.1% $0.000000 3,248 15 Feb 2026 Common Stock 250 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.